STROMECTOL 3 MG — DIN 02480557
IVERMECTIN : 3 MG · MERCK CANADA INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is STROMECTOL?
STROMECTOL 3 MG contains IVERMECTIN : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02480557, held by MERCK CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 06-Nov-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is STROMECTOL used for?
STROMECTOL® (ivermectin) is indicated for the treatment of: • intestinal strongyloidiasis; • onchocerciasis;
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Ivermectin cost around the world?
Ivermectin is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Iceland | max wholesale | 9 | 13 | ISK███.██ |
| United States | acquisition | 4 | 11 | USD███.██ |
| Australia | ex-manufacturer | 2 | 4 | AUD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 3 | EUR███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| United Arab Emirates | public | 1 | 2 | AED███.██ |
| Bahrain | retail (max) | 1 | 2 | BHD███.██ |
| Greece | producer price (ex-factory) | 2 | 2 | EUR███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Romania | max producer price | 1 | 1 | RON███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
45 pack listings across 30 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every Ivermectin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 3 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | STROMECTOL® tablets, 3 mg, are white, round, flat, bevel-edged tablets engraved with MSD on one side and 32 on the other side. They are supplied in unit dose packages in cartons of 4 tablets. |
| Storage | Store at 15-30°C. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Ivermectin |
|---|---|
| ATC code | P02CF01 |
| AHFS class | 08:08.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02480557 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2480557 |
| Brand name | STROMECTOL |
| Generic / active ingredient | IVERMECTIN : 3 MG |
| Market authorization holder | MERCK CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | P02CF01 |
| ATC anatomical main group | P — Antiparasitic products, insecticides and repellents |
| ATC therapeutic subgroup | P02CF |
| Current status | MARKETED |
| Status date | 06-Nov-2018 |
| Original market date | 2018-11-06 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
STROMECTOL® is administered as a single oral dose given with water on an empty stomach. Strongyloidiasis: The recommended dosage of STROMECTOL® for the treatment of strongyloidiasis is a single oral dose designed to provide approximately 200 mcg of ivermectin per kg of body weight. Patients should take tablets on an empty stomach with water. In general, additional doses are not necessary. However, follow-up stool examinations should be performed to verify eradication of infection. Onchocerciasis: The recommended dosage of STROMECTOL® for the treatment of onchocerciasis is a single oral dose designed to provide approximately 150 mcg/kg of body weight. Patients should take tablets on an empty stomach with water. In mass distribution campaigns for onchocerciasis, the most commonly used dose interval is 12 months. For the treatment of individual patients, retreatment may be considered at intervals as short as 3 months.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
STROMECTOL® is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
Warnings and precautions
Do not use STROMECTOL® if there is a history of hypersensitivity reaction to this product. Rarely, patients who are also heavily infected with Loa loa may develop a serious or even fatal encephalopathy either spontaneously or following treatment with an effective microfilaricide. In these patients, the following adverse experiences have also been reported: pain (including neck and back pain), red eye, conjunctival hemorrhage, dyspnea, urinary and/or fecal incontinence, difficulty in standing/walking, mental status changes, confusion, lethargy, stupor, seizures, or coma. This syndrome has been seen very rarely following the use of STROMECTOL®. In individuals who warrant treatment with STROMECTOL® for any reason and have had significant exposure to Loa loa-endemic areas of West or Central Africa, pretreatment assessment for loiasis and careful post-treatment follow-up should be implemented. Neurological toxicity, including depressed level of consciousness and coma, has also been reported in patients with the use of ivermectin in the absence of Loa loa infection. These events have generally resolved with supportive care and the discontinuation of ivermectin. After treatment with microfilaricidal drugs, patients with hyperreactive onchodermatitis (sowda) may be more likely than others to experience severe adverse reactions, especially edema and aggravation of onchodermatitis.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC P02CF
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ivermectin | STROMECTOL | 1 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC P02C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| P02CC | Pyrantel | 10 | 4 |
| P02CA | Mebendazole · Tiabendazole | 2 | 1 |
| P02CB | Diethylcarbamazine · Piperazine | 8 | 0 |
| P02CE | Levamisole | 2 | 0 |
| P02CX | Pyrvinium | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is STROMECTOL called?
Also recorded in Canada as: ivermectin 0.136 MG / pyrantel 114 MG Chewable Tablet [Heartgard Plus] (US), ivermectin 0.272 MG / pyrantel 227 MG Chewable Tablet [Heartgard Plus] (US), ivermectin 0.068 MG / pyrantel 57 MG Chewable Tablet [Heartgard Plus] (US), ivermectin 10 MG/ML Injectable Solution [Ivomec] (US), ivermectin 5 MG/ML Topical Solution [Ivomec] (US), ivermectin 0.0187 MG/MG Oral Paste [Bimectin] (US), ivermectin 10 MG/ML Injectable Solution [Agrimectin] (US), ivermectin 5 MG/ML Topical Lotion [Sklice] (US), ivermectin 0.8 MG/ML Oral Solution [Privermectin] (US), ivermectin 0.136 MG / pyrantel 114 MG Chewable Tablet [Tri-Heart Plus] (US), ivermectin 0.272 MG / pyrantel 227 MG Chewable Tablet [Tri-Heart Plus] (US), ivermectin 0.068 MG / pyrantel 57 MG Chewable Tablet [Tri-Heart Plus] (US), ivermectin 10 MG/ML Injectable Solution [Bimectin] (US), ivermectin 0.0187 MG/MG Oral Paste [DuraMectin] (US), ivermectin 5 MG/ML Topical Solution [Bimectin] (US).
The same molecule, Ivermectin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Soolantra | Latin | Bahrain, Czechia, Iceland, South Africa |
| Noromectin | Latin | Iceland |
| Bimectin Horse Oral Paste | Latin | Iceland |
| GLENMECT | Latin | Australia |
| Noromectin Drench | Latin | Iceland |
| Bimectin | Latin | Iceland |
| Eqvalan, vet. | Latin | Iceland |
| Ivermectin Medical Valley | Latin | Iceland |
| Ivomec, vet. | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.